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A B S T R A C T
Bone morphogenetic protein 7 (BMP-7) is a member of the transforming growth factor (TGF) beta superfamily and is
involved in regeneration, repair, and development of specific tissues, for example kidney and skeleton1–5. The experimen-
tal studies have shown its protective role against fibrotic processes. Tubulointerstitial changes are present in the pyelone-
phritic kidney which progresses to fibrosis4–6. Renal fibrosis may lead to the loss of renal function. The aim of this study
was to investigate BMP-7 expression in acute and chronic pyelonephritis in humans. Seven patients with acute pyelone-
phritis and 7 with chronic pyelonephritis were treated in Department of Nephrology Clinical Hospital, Rijeka. Tissue bi-
opsy was taken and renal tissue was studied histopathologically by use of hematoxylin and eosin and scored for diagno-
sis of pyelonephritis. BMP-7 expression was studied by imunohistochemical staining. BMP-7 expression was observed in
the tubular area of the pyelonephritic kidneys. The expression of BMP-7 was stronger in the acute pyelonephritic group
and less in the chronic pyelonephritic group of patients. The results imply that BMP-7 has a role in chronic pyelone-
phritis. Tubular BMP-7 expression had a negative correlation with fibrosis and tubular, atrophy. Our results are sug-
gesting that BMP-7 plays an important protective role in renal inflammatory diseases preventing greater damage and fi-
brosis.
Key words: bone morphogenetic proteins, kidney, inflammatory diseases
Introduction
Pyelonephritis is one of the most common serious in-
fections in children and early adulthood in many coun-
tries1. Progression of acute pyelonephritis into renal
scarring (chronic pyelonephritis) is around 10–40% and
postinfectious renal damage is still one of the major
causes of chronic renal failure1–3.
Bone morphogenetic proteins (BMPs) are members of
transforming growth factor-b (TGF-b) superfamily and
control multiple organogenetic processes: morphogene-
sis, cell proliferation and differentiation, apoptosis and
pattering of various organs on all three developmental
envelopes4–8. Only BMP-7 is absolutely required for pro-
per formation of the kidney6. The kidney has been identi-
fied as a major site of BMP-7 synthesis during embryonic
and postnatal development5–7. In postnatal life, many
developmental features are recapitulated during renal
injury, and BMPs are important in both preservation of
kidney function and resistance to injury9–11. In animal
models BMP-7 inhibits tubular epithelial cell de-differen-
tiation, mesenchyme transformation and apoptosis sti-
mulated by various renal injuries, has an anti-inflamma-
tory effect in both models of acute and chronic renal
failure, inhibits inflammatory cytokines IL-1 and
TNF-a1,4,5,7,9–11. In diabetic rats loss of BMP-7 expression
is associated with profibrotic activity12,13. In vitro studies
have demonstrated that BMP-7 inhibits TGF-b mediated
effects on renal cells and his production5. Exogenous ad-
ministration of rhBMP-7 reduces renal fibrogenesis and
apoptosis, also a reversal of renal fibrosis was observed
starting BMP-7 therapy several weeks after initial dama-
ge7,14,15. BMP-7 in ischemic acute renal failure prevents
neutrophil-mediated tissue damage, maintains the renal
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tubular epithelia in a mature and functional state by pre-
venting TGF-b1-mediated disruption of tubular epithe-
lial polarity and inhibits TGF-b mediated extracellular
matrix accumulation and collagen synthesis4. BMP-7 in
kidney is produced mostly by tubular epithelial cells and
glomerular podocytes4.
The aim of this study was to investigate BMP-7 ex-
pression in acute and chronic pyelonephritis in humans.
Material and Methods
Seven patients with acute pyelonephritis and 7 with
chronic pyelonephritis were treated at the Department
of Nephrology Clinical Medical Center of Rijeka, Rijeka,
Croatia. All patients have signed the informed consent.
True cut ultrasound guided tissue biopsy was taken for
clinical evaluation. Tissue specimens were fixed in 10%
buffered formalin and embedded in paraffin wax. Serial
sections at 3 µm thickness were made, mounted on glass
slides and kept at room temperature until use. The first 3
sequential sections from each specimen were stained
with hematoxylin and eosin (H&E) and with Masson’s
trichrome. To determine morphological data the cortico-
medullary part of the kidney including a minimum of 20
glomeruli was analyzed. The diagnosis of acute or chro-
nic pyelonephritis was made by an experienced patholo-
gist. Extensive fibrosis in chronic pyelonephritis was
proved with Masson’s trichrome staining. Semiquanti-
tative scoring was performed as 0 (Masson’s trichrome
staining not present), 1 (in <25% of tissue sample), 2 (in
25–50%) and 3 (in >50%)16. Scoring was performed by
three independent observers (S.Z., I.M. and J.S.) that
were blinded to patient outcome. Staining score of coun-
ted cells revealed a significant interobserver concordance.
Immunohistochemistry
Tissue slices were mounted on glass slides coated with
3-aminopropyltriethoxy silane (APES, Sigma, St. Louis,
MO, USA), air-dried, and stored at 4 °C until processing
for indirect immunoperoxidase staining. Briefly, tissue
slices were deparaffinized in xylene and rehydrated in
ethanol. Endogenous peroxidase and nonspecific binding
were blocked by incubation in 0.3% H202 in methanol and
10% non-immune serum. The sections were incubated
with primary antibody for 60 minutes at room tempera-
ture. Anti-BMP-7 were goat polyclonal antibodies pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). After the incubation with a primary antibody, sec-
ondary biotynilated antibody was applied according to
the manufacturer’s protocol (DAKO, LSAB@+ Kit Pero-
xidase, Carpentaria, CA, USA). Peroxidase conjugated
streptavidin was added and the site of antigen binding
was visualized using AEC + Substrate Chromogen (Da-
koCytomation). Sections were counterstained with he-
matoxylin. Slides used as negative control were pro-
cessed either with PBS buffer or the secondary antibody
alone.
Assessment of Immunohistochemistry
Semiquantitative scoring was performed as 0 (BMP-7
staining not present), 1 (in <25% of tissue sample), 2 (in
25–50%) and 3 (in >50%)16. Scoring was performed by
three independent observers (S.Z., I.M. and J.S.) that
were blinded to patient outcome. Staining score of coun-
ted cells revealed a significant interobserver concordance.
Satistical Analysis
The data was elaborated and analyzed using Statis-
tica 6.1 software package (StatSoft.lnc., Tulsa, OK, USA).
For comparison one-way ANOVA was used and post hoc
Bonferroni correction was applied. A value of p<0.01 was
required for significance.
Results
Histopathologically acute pyelonephritis was charac-
terized by polymorphonuclear leukocytes (PNL) infiltra-
tion of the interstitial tissue, interstitial oedema, PNL in
tubular lumen and the presence of tubulitis. Chronic
pyelonephritis was characterized by dominant mono-
nuclear cell infiltration, tubular atrophy, colloid casts in
dilated tubules, fibrosis and vascular changes. Fibrosis
was significantly stronger in chronic (1.9±0.6) compared
to acute (0.9±0.2) pyelonephritis. BMP-7 expression was
observed mostly in the tubulointerstitial area of the
pyelonephritic kidneys. The expression of BMP-7 (Figure
1, 2) was significantly (p<0.01) stronger in the acute
J. Spanjol et al.: Bone Morphogenetic Protein 7 and Pyelonephritis, Coll. Antropol. 34 (2010) Suppl. 2: 61–64
62
Fig. 1. Bone morphogenetic protein 7 expression in acute
pyelonephritis.
Fig. 2. Bone morphogenetic protein 7 expression in chronic
pyelonephritis.
pyelonephritis group (2.1±0.9) compared to chronic pye-
lonephritis group (0.9±0.2). Tubulointerstitial BMP-7
expression had a negative correlation (p<0.01) with fi-
brosis.
Discussion and Conclusions
Our results have demonstrated lower expression of
BMP-7 in the chronic human pyelonephritis. Also the
predominantly tubulointerstitial expression of BMP-7 is
negatively correlated with fibrosis and tubular atrophy.
Increased expression of BMP-7 in acute pyelonephritis is
available to inhibit further changes that characterize
chronic disease such as fibrosis.
Our findings on human material are consistent with
animal and in vitro studies. In animal models BMP-7 in-
hibits tubular epithelial cell de-differentiation, mesen-
chyme transformation and apoptosis, has an anti-inflam-
matory effect in both models of acute and chronic renal
failure, inhibits inflammatory cytokines IL-1 and
TNF-a1,4,5,7,9–11. Histopathologically in our study acute
pyelonephritis was characterized by polymorphonuclear
leukocytes (PNL) infiltration of the interstitial tissue, in-
terstitial oedema, PNL in tubular lumen and the pres-
ence of tubulitis. Chronic pyelonephritis was character-
ized by dominant mononuclear cell infiltration, tubular
atrophy, colloid casts in dilated tubules, fibrosis and vas-
cular changes10–20. With lower expression in chronic pye-
lonephritis the protective, antiinflamatory role of BMP-7
is minimalised. In diabetic rats loss of BMP-7 expression
is associated with profibrotic activity12,13. In vitro studies
have demonstrated that BMP-7 inhibits TGF-b mediated
effects on renal cells and his production5. Our results
also associate stronger fibrosis with lower BMP-expres-
sion. In animal model exogenous administration of
rhBMP-7 reduces renal fibrogenesis and apoptosis, also a
reversal of renal fibrosis was observed starting BMP-7
therapy several weeks after initial damage7,14,15. Accord-
ing to our results a possible therapeutic effect of BMP-7
implementation is to be considered in human patients.
In conclusion BMP-7 plays an important protective
role in renal inflammatory diseases preventing greater
damage and fibrosis. BMP-7 is mostly expressed in the
tubulointerstitial area of the kidney. Submission of
rh-BMP-7 in human patients with chronic pyelonephritis
may be an efficient therapeutic approach for preventing
further renal damage and advanced kidney failure.
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IZRA@AJ KO[TANOG MORFOGENETSKOG PROTEINA 7 U PIJELONEFRITISU LJUDI
S A @ E T A K
Ko{tani morfogenetski protein 7 (BMP-7) ~lan je superobitelji transformiraju}eg ~imbenika rasta (TGF) beta i uklju-
~en je u: regeneraciju, popravak i razvoj specifi~nih tkiva, npr. bubrega i skeleta1–5. Eksperimentalne studije pokazale
su za{titnu ulogu od procesa fibroze. Tubulointersticijske promjene izra`ene su u pijelonefritisu te postupno progre-
diraju u fibrozu4–6. Bubre`na fibroza mo`e dovesti do gubitka funkcije. Cilj ove studije bio je istra`iti izra`aj BMP-7 u
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pijelonefritisu ljudi. Sedam bolesnika s akutnim i 7 s kroni~nim pijelonefritisom, lije~enji su na Zavodu za nefrologiju i
dijalizu u Rijeci. U bolesnika je u~injena biopsija bubrega, a uzorci su obra|eni patohistolo{ki te je postavljena dijagnoza
pijelonefritisa. Izra`aj BMP-7 prou~avan je imunohistokemijski. Izra`aj BMP-7 zamije}en je tubulima bubrega zahva}e-
nih pijelonefritisom. Izra`aj BMP-7 bila je ja~a u akutnom pijelonefritisu nego li u kroni~nom. Rezultati upu}uju na
zaklju~ak kako BMP-7 ima ulogu u razvoju kroni~nog pijelonefritisa. Tubularni izra`aj BMP-7 imao je negativnu kore-
laciju s fibrozom i tubularnom atrofijom. Na{i rezultati sugeriraju kako BMP-7 ima potencijalno za{titnu ulogu u pro-
gresiji fibroze i tubularne atrofije u kroni~nom pijelonefritisu.
J. Spanjol et al.: Bone Morphogenetic Protein 7 and Pyelonephritis, Coll. Antropol. 34 (2010) Suppl. 2: 61–64
64
